Haleon plc

NYSE:HLN USA Drug Manufacturers - Specialty & Generic
Market Cap
$46.58 Billion
Market Cap Rank
#434 Global
#344 in USA
Share Price
$10.46
Change (1 day)
+4.29%
52-Week Range
$8.72 - $11.41
All Time High
$11.41
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more

Haleon plc (HLN) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: 0.071x

Based on the latest financial reports, Haleon plc (HLN) has a cash flow conversion efficiency ratio of 0.071x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.13 Billion) by net assets ($16.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Haleon plc - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Haleon plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Haleon plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Haleon plc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Haleon plc (2019–2024)

The table below shows the annual cash flow conversion efficiency of Haleon plc from 2019 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $16.22 Billion $2.30 Billion 0.142x +12.98%
2023-12-31 $16.73 Billion $2.10 Billion 0.126x +0.14%
2022-12-31 $16.46 Billion $2.06 Billion 0.125x +144.80%
2021-12-31 $26.48 Billion $1.36 Billion 0.051x -4.56%
2020-12-31 $26.22 Billion $1.41 Billion 0.054x +87.12%
2019-12-31 $27.41 Billion $786.00 Million 0.029x --